The Jakarta Post
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Popular Reads
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search results
Popular Reads
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search resultsIndonesia gives $1 million for CEPI vaccine efforts
Foreign Minister Retno Marsudi said Indonesia had contributed to promote “vaccine multilateralism”.
Change text size
Gift Premium Articles
to Anyone
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
Set as preferred source
I
ndonesia signed an agreement on Tuesday to contribute US$1 million to the Coalition for Epidemic Preparedness Innovations (CEPI), the largest global vaccine development initiative and a key player in the race to develop COVID-19 vaccines.
The deal was signed simultaneously by Foreign Ministry secretary general Cecep Herawan in Jakarta and CEPI chief executive officer (CEO) Richard Hatchett in London, marking Indonesia’s formal membership in the coalition.
Speaking after the ceremony, Foreign Minister Retno Marsudi said the latest news on the progress of vaccine development was encouraging but that a lot remained to be done and that Indonesia had contributed to promote “vaccine multilateralism”.
She said collaboration with CEPI was important because it would enable Indonesia to make concrete contributions to vaccination for all.
“We have made our position clear since the beginning of this pandemic. All countries deserve fair, affordable and equitable access to COVID-19 vaccines. Without it, developing and least developed countries are at risk of being left behind,” she said.
CEPI was founded in 2015 and has received backing from Bill and Melinda Gates Foundation, the Wellcome Trust and a number of countries, including Norway, Japan, Germany and the United Kingdom, as well as the European Union.
In its partnership with Indonesia, CEPI has selected state-owned pharmaceutical company Bio Farma to participate in the manufacturing of a COVID-19 vaccine after positive due diligence results.
